Sift heads world act 6 guide trial#

This news release includes statements containing certain 'forward-looking information' within the meaning of applicable securities law ('forward-looking statements').

Learn more at and follow us on Twitter and LinkedIn.Īurora's common shares trade on the NASDAQ and TSX under the symbol 'ACB'. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. New products launching this summer include:Īurora is opening the world to cannabis, serving both the medical and consumer markets.

Insights gleaned from the program will be used to develop future products and inform Aurora's innovation pipeline.

Sift heads world act 6 guide trial#

Through Aurora Lab, partners get behind-the-scenes access and sneak peeks at new products and formats, while invited patients get a chance to trial unreleased products in exchange for feedback. In addition to leveraging Aurora's best-in-class genetics breeding and research program, the company has launched Aurora Lab, an exclusive experiential research and education program designed to strengthen two-way conversations with patients, retailers, budtenders and consumers. The success of our Canadian innovation is applicable in key markets internationally and is receiving very positive patient feedback.' 'With the introduction of innovations like our snackable, low dose Lil' Bits and our XL premium resin vape pens, we're ensuring consumers and patients can find within Aurora's family of brands superior products as they progress on their cannabis journey. 'We continue to evolve our portfolio with the consumer and patient top-of-mind, developing products that deliver on both current and future wants and needs,' says Lana Culley, Vice President of Product Development at Aurora Cannabis.